Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study

Post time 2026-8-15 05:56:28

journal：Journal of Clinical Oncology

Authors：Alberto Garaventa; Ulrike Poetschger; Dominique Valteau-Couanet; Roberto Luksch; Victoria Castel; Martin Elliott; Shifra Ash; Godfrey C. F. Chan; Geneviève Laureys; Maja Beck-Popovic; Kim Vettenranta; Walentyna Balwierz; Henrik Schroeder; Cormac Owens; Maja Cesen; Vassilios Papadakis; Toby Trahair; Gudrun Schleiermacher; Peter Ambros; Stefania Sorrentino; Andrew D. J. Pearson; Ruth Lydia Ladenstein

Published date：2021-8-10

DOI：10.1200/jco.20.03144

PDF link：https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.03144

Article link：https://doi.org/10.1200/jco.20.03144

Article Source：American Society of Clinical Oncology (ASCO)。

Remark：

Post time 2026-8-15 05:56:29

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2026-8-15 06:00:59

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors